Skip to main content
SpringerLink
Log in

Ginsenoside Rb1 Deters Cell Proliferation, Induces Apoptosis, Alleviates Oxidative Stress, and Antimetastasis in Oral Squamous Carcinoma Cells

  • Original Article
  • Published:
Applied Biochemistry and Biotechnology Aims and scope Submit manuscript

Abstract

There are numerous therapeutic applications for ginsenoside Rb1 (GRb1), the primary saponin derived from ginseng root. According to earlier research, ginsenoside Rb1 causes apoptosis and reduces the cell cycle. Its adverse effects, especially those on the development of the embryo, still need to be thoroughly studied. A host’s lifestyle choices, including smoking, drinking too much alcohol, using tobacco products, and having an HPV infection, can increase the risk of oral squamous cell carcinoma (OSCC), one of the most prevalent malignancies of the oral cavity. To address this challenge, this investigation focuses on the design of GRb1 for treating OSCC. In vitro cytotoxicity studies confirmed that GRb1 was more effective in PCI-9A and PCI-13 cells, with reduced toxicity in non-cancerous cells. Further verification of cellular morphology was achieved through various biochemical staining methods. The mechanism of cell death was investigated by Annexin V-FITC and PI methods. Additionally, the antimetastatic attributes of GRb1 have been evaluated using both migration scratch and Transwell migration assays, which have collectively revealed excellent antimetastatic potential. The DNA fragmentation of the PCI-9A and PCI-13 cells was assessed using a comet assay. Ginsenoside Rb1 improved ROS levels and caused mitochondrial membrane potential alterations and DNA damage, which resulted in apoptosis. OSCC administration significantly reduced the levels of SOD, GSH, GPx, and CAT, increasing the levels of PCI-9A and PCI-13 cells, while GRb1 improved this situation. Therefore, we propose that Ginsenoside Rb1 could be an alternative therapeutic strategy for OSCC therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11

Similar content being viewed by others

Data Availability

All data generated or analyzed during this research are included in this published article.

References

  1. de Mendoza, I. L. I., Mendia, X. M., de la Fuente, A. M. G., Andres, G. Q., & Urizar, J. M. A. (2020). Role of Porphyromonas gingivalis in oral squamous cell carcinoma development: A systematic review. Journal of Periodontal Research, 55, 13–22.

    Article  Google Scholar 

  2. Das, N., Hussain, E., & Mahanta, L. B. (2020). Automated classification of cells into multiple classes in epithelial tissue of oral squamous cell carcinoma using transfer learning and convolutional neural network. Neural Networks, 128, 47–60.

    Article  PubMed  Google Scholar 

  3. Liu, L., Chen, J., Cai, X., Yao, Z., & Huang, J. (2019). Progress in targeted therapeutic drugs for oral squamous cell carcinoma. Surgical Oncology, 31, 90–97.

    Article  PubMed  Google Scholar 

  4. Cristaldi, M., Mauceri, R., Di Fede, O., Giuliana, G., Campisi, G., & Panzarella, V. (2019). Salivary biomarkers for oral squamous cell carcinoma diagnosis and follow-up: Current status and perspectives. Frontiers in Physiology, 10, 1476.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Jiang, X., Wu, J., Wang, J., & Huang, R. (2019). Tobacco and oral squamous cell carcinoma: A review of carcinogenic pathways. Tobacco Induced Diseases, 17.

  6. Capote-Moreno, A., Brabyn, P., Muñoz-Guerra, M. F., Sastre-Pérez, J., Escorial-Hernandez, V., Rodríguez-Campo, F. J., García, T., & Naval-Gías, L. (2020). Oral squamous cell carcinoma: Epidemiological study and risk factor assessment based on a 39-year series. International Journal of Oral and Maxillofacial Surgery, 49, 1525–1534.

    Article  CAS  PubMed  Google Scholar 

  7. Alabi, R. O., Youssef, O., Pirinen, M., Elmusrati, M., Mäkitie, A. A., Leivo, I., & Almangush, A. (2021). Machine learning in oral squamous cell carcinoma: Current status, clinical concerns and prospects for future—A systematic review. Artificial Intelligence in Medicine, 115, 102060.

    Article  PubMed  Google Scholar 

  8. Ling, Z., Cheng, B., & Tao, X. (2021). Epithelial-to-mesenchymal transition in oral squamous cell carcinoma: challenges and opportunities. International Journal of Cancer, 148, 1548–1561.

    Article  CAS  PubMed  Google Scholar 

  9. Bugshan, A., & Farooq, I. (2020). Oral squamous cell carcinoma: metastasis, potentially associated malignant disorders, etiology and recent advancements in diagnosis. F1000Research, 9.

  10. Almangush, A., Mäkitie, A. A., Triantafyllou, A., de Bree, R., Strojan, P., Rinaldo, A., Hernandez-Prera, J. C., Suárez, C., Kowalski, L. P., & Ferlito, A. (2020). Staging and grading of oral squamous cell carcinoma: An update. Oral Oncology, 107, 104799.

    Article  PubMed  Google Scholar 

  11. Li, H., & Li, H. (2020). Ginsenoside-Rg5 inhibits growth and metastasis of ovarian carcinoma via suppressing expression of fibroblast growth factor-8b (FGF8b). Journal of King Saud University-Science, 32, 1162–1167.

    Article  Google Scholar 

  12. Shan, K., Wang, Y., Hua, H., Qin, S., Yang, A., & Shao, J. (2019). Ginsenoside Rg3 combined with oxaliplatin inhibits the proliferation and promotes apoptosis of hepatocellular carcinoma cells via downregulating PCNA and cyclin D1. Biological and Pharmaceutical Bulletin, 42, 900–905.

    Article  CAS  PubMed  Google Scholar 

  13. Qu, L., Liu, Y., Deng, J., Ma, X., & Fan, D. (2023). Ginsenoside Rk3 is a novel PI3K/AKT-targeting therapeutics agent that regulates autophagy and apoptosis in hepatocellular carcinoma. Journal of Pharmaceutical Analysis, 13, 463–482.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Hong, H., Baatar, D., & Hwang, S. G. (2021). Anticancer activities of ginsenosides, the main active components of ginseng. Evidence-Based Complementary and Alternative Medicine, 2021.

  15. Zhu, H., He, Y.-S., Ma, J., Zhou, J., Kong, M., Wu, C.-Y., Mao, Q., Lin, G., & Li, S.-L. (2021). The dual roles of ginsenosides in improving the anti-tumor efficiency of cyclophosphamide in mammary carcinoma mice. Journal of Ethnopharmacology, 265, 113271.

    Article  CAS  PubMed  Google Scholar 

  16. Zhang, J., Ma, X., & Fan, D. (2021). Ginsenoside CK inhibits hypoxia-induced epithelial–mesenchymal transformation through the HIF-1α/NF-κB feedback pathway in hepatocellular carcinoma. Foods, 10, 1195.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Zhu, H., Wang, S.-Y., Zhu, J.-H., Liu, H., Kong, M., Mao, Q., Zhang, W., & Li, S.-L. (2021). Efficacy and safety of transcatheter arterial chemoembolization combined with ginsenosides in hepatocellular carcinoma treatment. Phytomedicine, 91, 153700.

    Article  CAS  PubMed  Google Scholar 

  18. Hwang, H. J., Hong, S. H., Moon, H. S., Yoon, Y. E., & Park, S. Y. (2022). Ginsenoside Rh2 sensitizes the anti-cancer effects of sunitinib by inducing cell cycle arrest in renal cell carcinoma. Scientific Reports, 12, 19752.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Qu, L., Ma, X., & Fan, D. (2021). Ginsenoside Rk3 suppresses hepatocellular carcinoma development through targeting the gut-liver axis. Journal of Agricultural and Food Chemistry, 69, 10121–10137.

    Article  CAS  PubMed  Google Scholar 

  20. Yang, X., Li, Y., & Qian, H. (2020). Study on the selection of the targets of esophageal carcinoma and interventions of ginsenosides based on network pharmacology and bioinformatics. Evidence-Based Complementary and Alternative Medicine, 2020.

  21. Ren, Z., Chen, X., Hong, L., Zhao, X., Cui, G., Li, A., Liu, Y., Zhou, L., Sun, R., Shen, S., Li, J., Lou, J., Zhou, H., Wang, J., Xu, G., Yu, Z., Song, Y., & Chen, X. (2020). Nanoparticle conjugation of ginsenoside Rg3 inhibits hepatocellular carcinoma development and metastasis. Small, 16, 1905233. https://doi.org/10.1002/smll.201905233

    Article  CAS  Google Scholar 

  22. Cai, L., Qin, X., Xu, Z., Song, Y., Jiang, H., Wu, Y., Ruan, H., & Chen, J. (2019). Comparison of cytotoxicity evaluation of anticancer drugs between real-time cell analysis and CCK-8 method. ACS Omega, 4, 12036–12042. https://doi.org/10.1021/acsomega.9b01142

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Li, J., Hu, S., Zhang, Z., Qian, L., Xue, Q., & Qu, X. (2020). LASP2 is downregulated in human liver cancer and contributes to hepatoblastoma cell malignant phenotypes through MAPK/ERK pathway. Biomedicine & Pharmacotherapy, 127, 110154. https://doi.org/10.1016/j.biopha.2020.110154

    Article  CAS  Google Scholar 

  24. Velmurugan, P., Shim, J., Bang, K.-S., & Oh, B.-T. (2016). Gold nanoparticles mediated coloring of fabrics and leather for antibacterial activity. Journal of Photochemistry and Photobiology B: Biology, 160, 102–109. https://doi.org/10.1016/j.jphotobiol.2016.03.051

    Article  CAS  PubMed  Google Scholar 

  25. Pan, W., Gong, S., Wang, J., Yu, L., Chen, Y., Li, N., & Tang, B. (2019). A nuclear-targeted titanium dioxide radiosensitizer for cell cycle regulation and enhanced radiotherapy. Chemical Communications, 55, 8182–8185. https://doi.org/10.1039/C9CC01651A

    Article  CAS  PubMed  Google Scholar 

  26. Rudrappa, M., Rudayni, H. A., Assiri, R. A., Bepari, A., Basavarajappa, D. S., Nagaraja, S. K., Chakraborty, B., Swamy, P. S., Agadi, S. N., Niazi, S. K., & Nayaka, S. (2022). Plumeria alba-mediated green synthesis of silver nanoparticles exhibits antimicrobial effect and anti-oncogenic activity against glioblastoma U118 MG cancer cell line. Nanomaterials, 12. https://doi.org/10.3390/nano12030493

  27. Li, K. G., Chen, J. T., Bai, S. S., Wen, X., Song, S. Y., Yu, Q., Li, J., & Wang, Y. Q. (2009). Intracellular oxidative stress and cadmium ions release induce cytotoxicity of unmodified cadmium sulfide quantum dots. Toxicology in Vitro, 23, 1007–1013. https://doi.org/10.1016/j.tiv.2009.06.020

    Article  CAS  PubMed  Google Scholar 

  28. Han, Y., Jiang, Y., Li, Y., Wang, M., Fan, T., Liu, M., Ke, Q., Xu, H., & Yi, Z. (2019). An aligned porous electrospun fibrous scaffold with embedded asiatic acid for accelerating diabetic wound healing. Journal of Materials Chemistry B, 7, 6125–6138. https://doi.org/10.1039/C9TB01327J

    Article  CAS  PubMed  Google Scholar 

  29. Chen, Q., Jiao, D., Yan, L., Wu, Y., Hu, H., Song, J., Yan, J., Wu, L., Xu, L., & Shi, J. (2015). Comprehensive gene and microRNA expression profiling reveals miR-206 inhibits MET in lung cancer metastasis. Molecular BioSystems, 11, 2290–2302. https://doi.org/10.1039/C4MB00734D

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of the Oral and Maxillofacial Surgery, the First Affiliated Hospital of Hainan Medical University, No.31, Longhua Road, Haikou, 570100, China

    Le An, Long He, Xu Xiao & Pengcheng Li

  2. Department of Oral Anatomy and Physiology, the First Affiliated Hospital of Harbin Medical University, Harbin, 150001, China

    Yang Yu

Authors
  1. Le An
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yang Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Long He
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Xu Xiao
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Pengcheng Li
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Le An, and Yang Yu: conceptualization, writing, data curation, software, writing original draft, methodology. Long He: analyzed and interpreted the data, resources, contributed reagents. Xu Xiao: materials, analysis data, software. Pengcheng Li: conceptualization, project administration, writing—review and editing

Corresponding author

Correspondence to Pengcheng Li.

Ethics declarations

Conflict of Interest

No potential conflict of interest was reported by the authors.

Ethics Approval

NA.

Consent to Participate

NA.

Consent for Publication

All authors agreed to publish this paper in this journal.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

An, L., Yu, Y., He, L. et al. Ginsenoside Rb1 Deters Cell Proliferation, Induces Apoptosis, Alleviates Oxidative Stress, and Antimetastasis in Oral Squamous Carcinoma Cells. Appl Biochem Biotechnol (2024). https://doi.org/10.1007/s12010-024-04880-z

Download citation

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12010-024-04880-z

Keywords

Search

Navigation